Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment

Brain, Behavior, and Immunity

Volumn 21, Issue 6, 2007, Pages 767-774

  Franchi, Silvia ^a   Panerai, Alberto E ^a   Sacerdote, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Buprenorphine; Corticosterone; Experimental metastasis; Natural killer cells; Opioids; Surgery induced immunosuppression

Indexed keywords

BUPRENORPHINE; CORTICOSTERONE; FENTANYL; MORPHINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; CELL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LUNG DIFFUSION; MALE; METASTASIS; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL STRESS;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BREAST NEOPLASMS; BUPRENORPHINE; CORTICOSTERONE; DISEASE MODELS, ANIMAL; FENTANYL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LAPAROTOMY; LUNG NEOPLASMS; MALE; MORPHINE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED F344; STRESS;

EID: 34347219410     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.01.001     Document Type: Article

References (52)

1. Alicea C., Belkowsky S., Eisenstein T.K., Adler M.W., and Rogers T.J. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50-488H. J. Neuroimmunol. 64 (1996) 83-90
2. Beilin B. Effect of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth. Analg. 82 (1996) 492-497
3. Beilin B., Shavit Y., Trabekin E., Mordashev B., Mayburd E., Zeidel A., and Bessler H. The effects of postoperative pain management on immune responses to surgery. Anesth. Analg. 97 (2003) 822-827
4. Ben-Eliyahu S. The price of anticancer intervention. Does surgery promote metastasis. Lancet Oncol. 3 (2002) 578-579
5. Ben-Eliyahu S., Page G.G., Yirmiya R., and Shakar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 80 (1999) 880-888
6. Colacchio T.A., Yeager M.P., and Hildebrandt L.W. Perioperative immunomodulation in cancer surgery. Am. J. Surg. 167 (1994) 174-179
7. D'Elia M., Patenaude J., Hamelin C., Garrel D.R., and Bernier J. No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters. Clin. Immunol. 109 (2003) 179-187
8. Eisenstein T.K., and Hilburger M.E. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83 (1998) 36-44
9. Evans H.C., and Easthope S. Transdermal buprenorphine. Drugs 63 (2003) 1999-2010
10. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276 (1996) 626-636
11. Freier D.D., and Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer activity. J. Pharmacol. Exp. Ther. 277 (1994) 633-645
12. Fujisawa T., and Yamaguchi Y. Autologous tumor killing activity as a prognostic factor in primary resected non small carcinoma of the lung. Cancer 79 (1997) 474-481
13. Gaspani L., Bianchi M., Limiroli E., Panerai A.E., and Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J. Neuroimmunol. 129 (2002) 18-24
14. Gaveriaux Ruff C., Simonin F., Filliol D., and Kieffer B.L. Enhanced humoral response in kappa-opioid receptor knock-out mice. J. Neuroimmunol. 134 (2003) 72-81
15. Gomez-Flores R., and Weber R. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periacqueductal gray. Immunopharmacology 48 (2000) 145-156
16. Gorelik E., Wiltrout R.H., Okumura K., Habu S., and Herberman R.B. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int. J. Cancer 30 (1982) 107-112
17. Hall M.D., Suo J.L., and Weber R.J. Opioid mediated effects on the immune system: sympathetic nervous system involvement. J. Neuroimmunol. 83 (1998) 29-35
18. Hanna N. The role of natural killer cells in the control of tumor growth and metastasis. Biochem. Biophys. Acta 780 (1985) 213-226
19. Hansbrough J.F., Bender E.M., Zapata-Sirvent R., and Anderson J. Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am. J. Surg. 148 (1984) 303-307
20. Hayes A.G., and Stewart B.R. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels. Eur. J. Pharmacol. 116 (1985) 75-79
21. Herberman R.B., and Ortaldo J.R. Natural killer cells: their role in defenses against disease. Science 214 (1981) 24-30
22. Koda K., Saito N., Takiguchi N., Oda K., Nunomura M., and Nakajima N. Preoperative natural killer cell activity: correlation with distant metastasis in curatively research colorectal carcinomas. Int. Surg. 82 (1997) 190-193
23. Lennard T.W., Shenton B.K., Borzotta A., Donnelly P.K., White M., Gerrie L.M., Proud G., and Taylor R.M. The influence of surgical operations on components of the human immune system. Br. J. Surg. 72 (1985) 771-776
24. Levy S.M., Herberman R.B., Moluish A.M., Schlien B., and Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol. 150 (1985) 199-214
25. Lotsch J. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom. Manage. 29 (2005) S90-S103
26. Martucci C., Panerai A.E., and Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 110 (2004) 385-392
27. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudaram N., and Ben-Eliyahu S. Marginating pulmonary NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and prostaglandin synthesis inhibitors. Brain Behav. Immun. 19 (2005) 114-126
28. Neri S., Bruno C.M., Pulvirenti D., Malaguarnera M., Italiano C., Mauceri B., Abate G., Cilio D., Calcagno S., Tsami A., Ignaccolo L., Interlandi D., Prestianni L., Ricchena M., and Noto R. Randomized clinical trial to compare the effect s of metadone and buprenorphine on the immune system in drug abusers. Psychopharmacology 179 (2005) 700-704
29. Ohtani M., Kotaki H., Uchino K., Sawada Y., and Iga T. Pharmacokinetic analysis of entherohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Drug. Metab. Dispos. 22 (1994) 2-7
30. Page G.G., Ben-Eliyahu S., and Liebeskind G.C. The role of LGL, NK cells in surgery induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 8 (1994) 241-250
31. Page G.G., Ben-Eliyahu S., and Taylor A.N. The development of sexual dimorphism in natural killer cell activity and resistance to tumor metastasis in the Fisher 344 rat. J. Neuroimmunol. 63 (1995) 69-77
32. Page G.G., McDonald J.S., and Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural and metastatic-enhancing effects of surgery. Br. J. Anaesth. 81 (1998) 216-223
33. Page G.G., Blakely W.P., and Ben-Eliyhau S.B. Evidence that post-operative pain is a mediator of the tumor promoting effects of surgery in rats. Pain (2001) 191-199
34. Payne J.H., Baigrie R.J., Lamont P.M., Morris P.J., and Newsholme E.A. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch. Surg. 129 (1992) 973-979
35. Peterson P.K., Molitor T.W., and Chao C.C. Mechanism of morphine-induced immunomodulation. Biochem. Pharmacol. 46 (1993) 343-348
36. Pollok R.E., Lotzova E., and Stanford S.D. Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. Arch. Surg. 126 (1991) 338-342
37. Roughan J.V., and Flecknell P.A. Behaviour-based assessment of the duration of laparotomy-induced abdominal pain and the analgesic effects of carprofen and buprenorphine in rats. Behavioural Pharmacol. 15 (2004) 461-472
38. Sacerdote P., Manfredi B., Mantegazza P., and Panerai A.E. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br. J . Pharmacol. 121 (1997) 834-840
39. Sacerdote P., Bianchi M., Manfredi B., and Panerai A.E. Effects of tramadol on immune responses and nociceptive thresholds in mice. Pain 72 (1997) 325-330
40. Sacerdote P., Bianchi M., Gaspani L., Manfredi B., Maucione A., Terno G., and Panerai A.E. Effect of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth. Analg. 90 (2000) 1411-1414
41. Saito T., Kinoshita T., Shigemitsu Y., Katsuta T., Shimoda K., and Kobayashi M. Impaired humoral immunity is associated with development of methicillin-resistant Staphylococcus aureus infections after esophageal surgery. J. Infect. Dis. 166 (1992) 1459-1460
42. Schantz S.P., Brown B.W., Lira E., Taylor D.L., and Beddingfield N. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol. Immunother. 25 (1987) 141-148
43. Shavit Y., Ben-Eliyahu S., Zeidel A., and Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Neuroimmunomodulation 11 (2004) 255-260
44. Tartre P.I., Steinberg B., Barron D.M., and Martinelli G. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch. Surg. 122 (1987) 1264-1268
45. Udelsman R., Blake M.J., and Holbrook N.J. Molecular response to surgical stress: specific and simultaneous heat shock protein induction in the adrenal cortex, aorta and vena cava. Surgery 110 (1991) 1125-1131
46. Vallejo R., De Leon-Casasola O., and Benyamin R. Opioid therapy and immunosuppression. Am. J. Ther. 11 (2004) 354-365
47. Wang J., Charboneau R., Balasubramian S., Barke R.A., Loh H.H., and Roy S. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu opioid receptor. J. Leukoc. Biol. 71 (2002) 782-790
48. Wiltrout R.H., Herberman R.B., Zhang S.R., Chirigos M.A., Ortaldo J.R., Green K.M., and Talmadge J.E. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J. Immunol. 134 (1985) 4267-4275
49. Yassen A., Olofsen E., Dahan A., and Danhof M. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: Role of receptor equilibration kinetics. J. Pharmacol. Exp. Ther. 313 (2005) 1136-1149
50. Yeager M.P., and Colacchio T.A. Effect of morphine on growth of metastatic colon cancer in vivo. Arch. Surg. 126 (1991) 454-456
51. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., and Guyre M. Morphine inhibits spontaneous and cytokine enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83 (1996) 500-508
52. Yokota T., Uehara K., and Nomoto Y. Intrathecal morphine suppresses NK activity following abdominal surgery. Can. J. Anaesth. 47 (2000) 303-308